Table S2. PRISMA-DTA checklist for abstract.
| Section/topic | # | PRISMA-DTA for abstracts checklist item | Reported on page # |
|---|---|---|---|
| Title and purpose | |||
| Title | 1 | Identify the report as a systematic review (+/− meta-analysis) of diagnostic test accuracy (DTA) studies | 1 |
| Objectives | 2 | Indicate the research question, including components such as participants, index test, and target conditions | 1 |
| Methods | |||
| Eligibility criteria | 3 | Include study characteristics used as criteria for eligibility | 1 |
| Information sources | 4 | List the key databases searched and the search dates | 1 |
| Risk of bias & applicability | 5 | Indicate the methods of assessing risk of bias and applicability | 1 |
| Synthesis of results | A1 | Indicate the methods for the data synthesis | 1 |
| Results | |||
| Included studies | 6 | Indicate the number and type of included studies and the participants and relevant characteristics of the studies (including the reference standard) | 1 |
| Synthesis of results | 7 | Include the results for the analysis of diagnostic accuracy, preferably indicating the number of studies and participants. Describe test accuracy including variability; if meta-analysis was done, include summary results and confidence intervals | 1 |
| Discussion | |||
| Strengths and limitations | 9 | Provide a brief summary of the strengths and limitations of the evidence | 1 |
| Interpretation | 10 | Provide a general interpretation of the results and the important implications | 1 |
| Other | |||
| Funding | 11 | Indicate the primary source of funding for the review | NA |
| Registration | 12 | Provide the registration number and the registry name | NA |
For more information, visit: www.prisma-statement.org. NA, not applicable.